ARTICLES BY THIS AUTHOR
- 4/15/2024
Two CVS pharmacies in Rhode Island file to unionize
Pharmacy professionals at a CVS in Las Vegas are set to have a union election April 24. - 4/18/2024
Upsher-Smith previews expansion of rare disease portfolio at 2024 AAN annual meeting
Upsher-Smith has broadened its offerings to include Vigadrone (vigabatrin) Tablets, 500 mg. Torpenz Tablets, a branded-generic everolimus tablet, will soon be available to prescribers and patients. - 4/17/2024
Strides Pharma obtains FDA OK for generic Prozac
Fluoxetine is used for the treatment of major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder, with or without agoraphobia. - 4/17/2024
ANI debuts generic Fleqsuvy
Generic Fleqsuvy is a treatment for spasticity from multiple sclerosis, spinal cord injuries and other spinal cord diseases. - 4/18/2024
CRN adopts new guidelines for melatonin supplements, gummy supplements
The guidelines center around formulation, labeling and packaging of melatonin and gummy supplements. - 4/16/2024
Samsung Bioepis releases Q2 2024 U.S. biosimilar market report
As of April 2024, the FDA has approved a total of 48 biosimilars across 15 unique biological molecules, and of the 48 approvals, 38 biosimilars have launched in the U.S. market, per the report. - 4/15/2024
SpartanNash acquires Metcalfe’s Market
SpartanNash has acquired the three-store Wisconsin grocer, and will continue employment for all of Metcalfe’s Market employees. - 4/16/2024
Avenacy debuts generic DDAVP
Desmopressin acetate for injection is multi-indicated for patients with central diabetes insipidus, hemophilia A and von Willebrand’s disease. - 4/15/2024
Lupin gets approval for generic Ingrezza, launches generic Oracea
Lupin is one of the first ANDA applicants for generic Ingrezza and is eligible for 180 days of shared generic exclusivity. - 4/17/2024
The Ginger People debuts new lozenges
The Ginger Rescue Lozenges are available in hard and soft formats.